{"id":18519,"date":"2023-08-10T15:02:07","date_gmt":"2023-08-10T14:02:07","guid":{"rendered":"https:\/\/psychedelichealth.co.uk\/?p=18519"},"modified":"2023-08-10T15:30:23","modified_gmt":"2023-08-10T14:30:23","slug":"study-psilocybin-gambling-addiction","status":"publish","type":"post","link":"https:\/\/psychedelichealth.co.uk\/2023\/08\/10\/study-psilocybin-gambling-addiction\/","title":{"rendered":"World first study to explore psilocybin for gambling addiction"},"content":{"rendered":"<h3><b>Marking a world first, researchers at Imperial\u2019s Centre for Psychedelic Research will investigate psilocybin as a treatment for gambling addiction with the support of funding from the UK Research and Innovation (UKRI) fund.<\/b><\/h3>\n<p><span style=\"font-weight: 400;\">The Centre will be carrying out a small study involving five volunteers with gambling addiction to test if psychedelic therapy is safe and could have therapeutic potential.<\/span><\/p>\n<p><span style=\"font-weight: 400;\">From October 2023, the volunteers will be given psilocybin in combination with talking therapy and will undergo braing imaging to monitor patterns of brain acitivity and connectivity using functional magnetic resonance imaging (fMRI) and electroencephalography (EEG).<\/span><\/p>\n<p><span style=\"font-weight: 400;\">The study is being led by leading researchers in the field, including Professor David Nutt, Dr David Erritzoe, Dr Matt Wall and Rayyan Zafar, PhD, from Imperial College Centre for Psychedelic Research and Neuropsychopharmacology.<\/span><\/p>\n<div style=\"clear:both; margin-top:0em; margin-bottom:1em;\"><a href=\"https:\/\/psychedelichealth.co.uk\/2023\/08\/08\/psilocybin-therapy-anorexia-positive-results\/\" target=\"_blank\" rel=\"dofollow\" class=\"u9d60cbf45102d909c0e22db1c1f6e844\"><style> .u9d60cbf45102d909c0e22db1c1f6e844 { padding:0px; margin: 0; padding-top:1em!important; padding-bottom:1em!important; width:100%; display: block; font-weight:bold; background-color:#eaeaea; border:0!important; border-left:4px solid #34495E!important; text-decoration:none; } .u9d60cbf45102d909c0e22db1c1f6e844:active, .u9d60cbf45102d909c0e22db1c1f6e844:hover { opacity: 1; transition: opacity 250ms; webkit-transition: opacity 250ms; text-decoration:none; } .u9d60cbf45102d909c0e22db1c1f6e844 { transition: background-color 250ms; webkit-transition: background-color 250ms; opacity: 1; transition: opacity 250ms; webkit-transition: opacity 250ms; } .u9d60cbf45102d909c0e22db1c1f6e844 .ctaText { font-weight:bold; color:inherit; text-decoration:none; font-size: 16px; } .u9d60cbf45102d909c0e22db1c1f6e844 .postTitle { color:#000000; text-decoration: underline!important; font-size: 16px; } .u9d60cbf45102d909c0e22db1c1f6e844:hover .postTitle { text-decoration: underline!important; } <\/style><div style=\"padding-left:1em; padding-right:1em;\"><span class=\"ctaText\">See also<\/span>&nbsp; <span class=\"postTitle\">Psilocybin therapy for anorexia shows positive results<\/span><\/div><\/a><\/div>\n<p><span style=\"font-weight: 400;\">As psychedelics have shown promise in clinical research as potentially innovative treatments for conditions such as depression, post-traumatic stress disorder (PTSD), alcoholism and more, the team believes that psilocybin may offer hope as a treatment for gambling disorder.<\/span><\/p>\n<p><span style=\"font-weight: 400;\">Psilocybin, in particular, has been shown in a <a href=\"https:\/\/www.frontiersin.org\/articles\/10.3389\/fpsyt.2021.724606\/full\" target=\"_blank\" rel=\"noopener\">number of clinical studies<\/a> to induce brain plasticity, with research proposing this creates a window of time following a psilocybin experience that enables a person to break old patterns of thinking and form new ones &#8211; helping people break addictive patterns of behaviour.\u00a0<\/span><\/p>\n<p><span style=\"font-weight: 400;\">Between April and December 2022, the UK saw record demand for gambling services, with referrals to NHS clinics for gambling addiction up by 16.2% from the same period in 2021, and the north of England having the highest prevalence of at-risk gamblers.<\/span><\/p>\n<div style=\"clear:both; margin-top:0em; margin-bottom:1em;\"><a href=\"https:\/\/psychedelichealth.co.uk\/2023\/08\/02\/entourage-effect-psychedelic-mushrooms\/\" target=\"_blank\" rel=\"dofollow\" class=\"u1cdb62dfb47609b4e9d224251cf1f1f6\"><style> .u1cdb62dfb47609b4e9d224251cf1f1f6 { padding:0px; margin: 0; padding-top:1em!important; padding-bottom:1em!important; width:100%; display: block; font-weight:bold; background-color:#eaeaea; border:0!important; border-left:4px solid #34495E!important; text-decoration:none; } .u1cdb62dfb47609b4e9d224251cf1f1f6:active, .u1cdb62dfb47609b4e9d224251cf1f1f6:hover { opacity: 1; transition: opacity 250ms; webkit-transition: opacity 250ms; text-decoration:none; } .u1cdb62dfb47609b4e9d224251cf1f1f6 { transition: background-color 250ms; webkit-transition: background-color 250ms; opacity: 1; transition: opacity 250ms; webkit-transition: opacity 250ms; } .u1cdb62dfb47609b4e9d224251cf1f1f6 .ctaText { font-weight:bold; color:inherit; text-decoration:none; font-size: 16px; } .u1cdb62dfb47609b4e9d224251cf1f1f6 .postTitle { color:#000000; text-decoration: underline!important; font-size: 16px; } .u1cdb62dfb47609b4e9d224251cf1f1f6:hover .postTitle { text-decoration: underline!important; } <\/style><div style=\"padding-left:1em; padding-right:1em;\"><span class=\"ctaText\">See also<\/span>&nbsp; <span class=\"postTitle\">Exploring the entourage effect in psychedelic mushrooms<\/span><\/div><\/a><\/div>\n<p><span style=\"font-weight: 400;\">Zafar told <\/span><i><span style=\"font-weight: 400;\">Psychedelic Health<\/span><\/i><span style=\"font-weight: 400;\">: \u201cThe current clinical treatment paradigm for gambling addiction in the UK is a psychosocial intervention such as Cognitive Behavioural Therapy (CBT) with some patients being prescribed naltrexone off-label. To date, there are no licensed pharmacological interventions for Gambling Disorder.\u201d<\/span><\/p>\n<p><span style=\"font-weight: 400;\">Zaffar highlights that recent studies have shown the therapeutic potential of <a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/32243793\/\" target=\"_blank\" rel=\"noopener\">Psychedelic Therapy in the treatment of psychiatric conditions,<\/a> including <a href=\"https:\/\/jamanetwork.com\/journals\/jamapsychiatry\/fullarticle\/2795625\" target=\"_blank\" rel=\"noopener\">substance use disorders,<\/a> but there have been no specific studies into the use of Psychedelic Therapy to treat Gambling Addiction or other behavioral addictions.\u00a0<\/span><\/p>\n<p><span style=\"font-weight: 400;\">\u201cGiven the similarities in clinical and brain characteristics between substance use addictions and behavioural addictions we believe psychedelics may be able to target the same psychological and physiological mechanisms underlying this condition,\u201d said Zafar.\u00a0<\/span><\/p>\n<p><span style=\"font-weight: 400;\">\u201cThere is currently a large unmet medical need for effective interventional solutions for these individuals given the lack of available or effective treatments.<\/span><\/p>\n<p><span style=\"font-weight: 400;\">\u201cResearch in psychiatry and addiction has been largely led through serendipitous discovery and this has led to a lack of understanding about disorder pathology and the mechanism of action of therapeutic interventions which has contributed to the large treatment gap that exists in addiction medicine.<\/span><\/p>\n<p><span style=\"font-weight: 400;\">\u201cIn recent years there have been efforts to incorporate personalised medicine and precision psychiatry approaches utilising human neuroimaging in early phase human addiction clinical research.\u201d<\/span><\/p>\n<p><span style=\"font-weight: 400;\">Zafar emphasises such research has enabled the identification of novel drug targets and mechanisms of action of interventions, allowing for neuroscience-informed drug development, and paving the way for <a href=\"https:\/\/journals.sagepub.com\/doi\/10.1177\/0269881116668592?icid=int.sj-full-text.similar-articles.3\" target=\"_blank\" rel=\"noopener\">more effective interventions<\/a> to reach addiction clinics.\u00a0<\/span><\/p>\n<p><span style=\"font-weight: 400;\">fMRI and EEG can be used to identify translational biomarkers that are observable in patients with addiction disorders and that may respond to interventions such as psychedelic therapy, explains Zafar.\u00a0<\/span><\/p>\n<p><span style=\"font-weight: 400;\">\u201cIntegrating these techniques into early phase clinical research of novel interventions like psychedelic therapy is therefore critical to enable for optimal translation,\u201d he said.<\/span><\/p>\n<p><span style=\"font-weight: 400;\">\u201cWe are currently completing a series of experiments to develop such translational neuroimaging biomarkers for Gambling Didorder using tasks developed in our lab to probe the brain\u2019s reward and plasticity systems which are known to be dysregulated in Gambling Disorder.\u00a0<\/span><\/p>\n<p><span style=\"font-weight: 400;\">\u201cOur tasks were created to explore the hypotheses that in Gambling Disorder, there is maladaptive reward processing and neuroplasticity which are contributing to the pathology of the disorder.\u00a0<\/span><\/p>\n<p><span style=\"font-weight: 400;\">\u201cThese tasks have been validated as part of my PhD and we know these areas are possible targets for psychedelics &#8211; we want to see whether psychedelics can target these systems involved in Gambling Disorder and whether that is how they lead to their therapeutic effects.\u201d<\/span><\/p>\n<p><span style=\"font-weight: 400;\">With psychedelic research in the UK receiving minimal state funding to date, the UKRI investment is symbolic of changing attitudes towards psychedelic science.\u00a0<\/span><\/p>\n<p><span style=\"font-weight: 400;\">\u201cHaving support like this is a big step forward for psychedelic research in the UK and we hope this will catalyse more of the same in the future,\u201d said Zafar.\u00a0<\/span><\/p>\n<p><span style=\"font-weight: 400;\">\u201cThe UK is a global leader in psychedelic research and if we are to keep this up we will need sufficient R&amp;D support and funding from institutions and the Government.\u201d<\/span><\/p>\n<p><span style=\"font-weight: 400;\">The Centre received UKRI funding following its groundbreaking <a href=\"https:\/\/link.springer.com\/article\/10.1007\/s00213-017-4771-x\" target=\"_blank\" rel=\"noopener\">research<\/a> investigating psilocybin in combination with talking therapy for depression which showed reductions in depressive symptoms, and another <a href=\"https:\/\/journals.sagepub.com\/doi\/10.1177\/02698811231167848\" target=\"_blank\" rel=\"noopener\">study<\/a> exploring psilocybin versus Escitalopram for depression, showing secondary outcomes favored psilocybin over escitalopram.<\/span><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Marking a world first, researchers at Imperial\u2019s Centre for Psychedelic Research will investigate psilocybin as a treatment for gambling addiction with the support of funding from the UK Research and Innovation (UKRI) fund. The Centre will be carrying out a small study involving five volunteers with gambling addiction to test if psychedelic therapy is safe [&hellip;]<\/p>\n","protected":false},"author":20,"featured_media":17282,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_cbd_carousel_blocks":"[]","content-type":"","_monsterinsights_skip_tracking":false,"_monsterinsights_sitenote_active":false,"_monsterinsights_sitenote_note":"","_monsterinsights_sitenote_category":0,"footnotes":""},"categories":[215],"tags":[95,48,223],"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v18.1 (Yoast SEO v22.4) - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>Imperial College London first study psilocybin gambling addiction<\/title>\n<meta name=\"description\" content=\"Marking a world first, researchers at Imperial\u2019s Centre for Psychedelic Research will investigate psilocybin as a treatment for gambling addiction with the support of funding from the UK Research and Innovation (UKRI) fund.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/psychedelichealth.co.uk\/2023\/08\/10\/study-psilocybin-gambling-addiction\/\" \/>\n<meta property=\"og:locale\" content=\"en_GB\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"World first study to explore psilocybin for gambling addiction\" \/>\n<meta property=\"og:description\" content=\"Marking a world first, researchers at Imperial\u2019s Centre for Psychedelic Research will investigate psilocybin as a treatment for gambling addiction with the support of funding from the UK Research and Innovation (UKRI) fund.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/psychedelichealth.co.uk\/2023\/08\/10\/study-psilocybin-gambling-addiction\/\" \/>\n<meta property=\"og:site_name\" content=\"Psychedelic Health\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/Cannabis-Health-Magazine-1047415772315886\/?ref=bookmarks\" \/>\n<meta property=\"article:published_time\" content=\"2023-08-10T14:02:07+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2023-08-10T14:30:23+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/psychedelichealth.co.uk\/wp-content\/uploads\/2022\/04\/AdobeStock_186924260.jpeg\" \/>\n\t<meta property=\"og:image:width\" content=\"1200\" \/>\n\t<meta property=\"og:image:height\" content=\"747\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Stephanie Price\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:creator\" content=\"@https:\/\/twitter.com\/steph_jprice\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Stephanie Price\" \/>\n\t<meta name=\"twitter:label2\" content=\"Estimated reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"4 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/psychedelichealth.co.uk\/2023\/08\/10\/study-psilocybin-gambling-addiction\/\",\"url\":\"https:\/\/psychedelichealth.co.uk\/2023\/08\/10\/study-psilocybin-gambling-addiction\/\",\"name\":\"Imperial College London first study psilocybin gambling addiction\",\"isPartOf\":{\"@id\":\"https:\/\/34.142.66.208\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/psychedelichealth.co.uk\/2023\/08\/10\/study-psilocybin-gambling-addiction\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/psychedelichealth.co.uk\/2023\/08\/10\/study-psilocybin-gambling-addiction\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/psychedelichealth.co.uk\/wp-content\/uploads\/2022\/04\/AdobeStock_186924260.jpeg\",\"datePublished\":\"2023-08-10T14:02:07+00:00\",\"dateModified\":\"2023-08-10T14:30:23+00:00\",\"author\":{\"@id\":\"https:\/\/34.142.66.208\/#\/schema\/person\/188c12739a5906cf0b69fbf53f517f12\"},\"description\":\"Marking a world first, researchers at Imperial\u2019s Centre for Psychedelic Research will investigate psilocybin as a treatment for gambling addiction with the support of funding from the UK Research and Innovation (UKRI) fund.\",\"breadcrumb\":{\"@id\":\"https:\/\/psychedelichealth.co.uk\/2023\/08\/10\/study-psilocybin-gambling-addiction\/#breadcrumb\"},\"inLanguage\":\"en-GB\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/psychedelichealth.co.uk\/2023\/08\/10\/study-psilocybin-gambling-addiction\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-GB\",\"@id\":\"https:\/\/psychedelichealth.co.uk\/2023\/08\/10\/study-psilocybin-gambling-addiction\/#primaryimage\",\"url\":\"https:\/\/psychedelichealth.co.uk\/wp-content\/uploads\/2022\/04\/AdobeStock_186924260.jpeg\",\"contentUrl\":\"https:\/\/psychedelichealth.co.uk\/wp-content\/uploads\/2022\/04\/AdobeStock_186924260.jpeg\",\"width\":1200,\"height\":747,\"caption\":\"UK funds world\u2019s first study exploring psilocybin for gambling addiction\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/psychedelichealth.co.uk\/2023\/08\/10\/study-psilocybin-gambling-addiction\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/34.142.66.208\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"World first study to explore psilocybin for gambling addiction\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/34.142.66.208\/#website\",\"url\":\"https:\/\/34.142.66.208\/\",\"name\":\"Psychedelic Health\",\"description\":\"News\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/34.142.66.208\/?s={search_term_string}\"},\"query-input\":\"required name=search_term_string\"}],\"inLanguage\":\"en-GB\"},{\"@type\":\"Person\",\"@id\":\"https:\/\/34.142.66.208\/#\/schema\/person\/188c12739a5906cf0b69fbf53f517f12\",\"name\":\"Stephanie Price\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-GB\",\"@id\":\"https:\/\/34.142.66.208\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/psychedelichealth.co.uk\/wp-content\/uploads\/2023\/05\/avatar_user_20_1684313043-96x96.jpg\",\"contentUrl\":\"https:\/\/psychedelichealth.co.uk\/wp-content\/uploads\/2023\/05\/avatar_user_20_1684313043-96x96.jpg\",\"caption\":\"Stephanie Price\"},\"description\":\"Stephanie is the editor of Psychedelic Health. Contact: stephanie@psych.global. Stephanie is a journalist writing about science, research, policy and industry developments in cannabis, CBD and psychedelics. In 2013 Stephanie gained her BA in English and Media, focusing on journalism and propaganda, and in 2015, received her National Council for the Training of Journalists (NCTJ) diploma whilst working as a reporter in North Wales. Stephanie has a specialism in Medical Cannabis: The Health Effects of THC and CBD through the University of Colorado, Boulder, and a certificate from the Medical Cannabis Clinicians Society on \\\"Medical Cannabis Explained\\\".\",\"sameAs\":[\"https:\/\/psychedelichealth.co.uk\",\"https:\/\/twitter.com\/https:\/\/twitter.com\/steph_jprice\"],\"url\":\"https:\/\/psychedelichealth.co.uk\/author\/stephanieprice\/\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"Imperial College London first study psilocybin gambling addiction","description":"Marking a world first, researchers at Imperial\u2019s Centre for Psychedelic Research will investigate psilocybin as a treatment for gambling addiction with the support of funding from the UK Research and Innovation (UKRI) fund.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/psychedelichealth.co.uk\/2023\/08\/10\/study-psilocybin-gambling-addiction\/","og_locale":"en_GB","og_type":"article","og_title":"World first study to explore psilocybin for gambling addiction","og_description":"Marking a world first, researchers at Imperial\u2019s Centre for Psychedelic Research will investigate psilocybin as a treatment for gambling addiction with the support of funding from the UK Research and Innovation (UKRI) fund.","og_url":"https:\/\/psychedelichealth.co.uk\/2023\/08\/10\/study-psilocybin-gambling-addiction\/","og_site_name":"Psychedelic Health","article_publisher":"https:\/\/www.facebook.com\/Cannabis-Health-Magazine-1047415772315886\/?ref=bookmarks","article_published_time":"2023-08-10T14:02:07+00:00","article_modified_time":"2023-08-10T14:30:23+00:00","og_image":[{"width":1200,"height":747,"url":"https:\/\/psychedelichealth.co.uk\/wp-content\/uploads\/2022\/04\/AdobeStock_186924260.jpeg","type":"image\/jpeg"}],"author":"Stephanie Price","twitter_card":"summary_large_image","twitter_creator":"@https:\/\/twitter.com\/steph_jprice","twitter_misc":{"Written by":"Stephanie Price","Estimated reading time":"4 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/psychedelichealth.co.uk\/2023\/08\/10\/study-psilocybin-gambling-addiction\/","url":"https:\/\/psychedelichealth.co.uk\/2023\/08\/10\/study-psilocybin-gambling-addiction\/","name":"Imperial College London first study psilocybin gambling addiction","isPartOf":{"@id":"https:\/\/34.142.66.208\/#website"},"primaryImageOfPage":{"@id":"https:\/\/psychedelichealth.co.uk\/2023\/08\/10\/study-psilocybin-gambling-addiction\/#primaryimage"},"image":{"@id":"https:\/\/psychedelichealth.co.uk\/2023\/08\/10\/study-psilocybin-gambling-addiction\/#primaryimage"},"thumbnailUrl":"https:\/\/psychedelichealth.co.uk\/wp-content\/uploads\/2022\/04\/AdobeStock_186924260.jpeg","datePublished":"2023-08-10T14:02:07+00:00","dateModified":"2023-08-10T14:30:23+00:00","author":{"@id":"https:\/\/34.142.66.208\/#\/schema\/person\/188c12739a5906cf0b69fbf53f517f12"},"description":"Marking a world first, researchers at Imperial\u2019s Centre for Psychedelic Research will investigate psilocybin as a treatment for gambling addiction with the support of funding from the UK Research and Innovation (UKRI) fund.","breadcrumb":{"@id":"https:\/\/psychedelichealth.co.uk\/2023\/08\/10\/study-psilocybin-gambling-addiction\/#breadcrumb"},"inLanguage":"en-GB","potentialAction":[{"@type":"ReadAction","target":["https:\/\/psychedelichealth.co.uk\/2023\/08\/10\/study-psilocybin-gambling-addiction\/"]}]},{"@type":"ImageObject","inLanguage":"en-GB","@id":"https:\/\/psychedelichealth.co.uk\/2023\/08\/10\/study-psilocybin-gambling-addiction\/#primaryimage","url":"https:\/\/psychedelichealth.co.uk\/wp-content\/uploads\/2022\/04\/AdobeStock_186924260.jpeg","contentUrl":"https:\/\/psychedelichealth.co.uk\/wp-content\/uploads\/2022\/04\/AdobeStock_186924260.jpeg","width":1200,"height":747,"caption":"UK funds world\u2019s first study exploring psilocybin for gambling addiction"},{"@type":"BreadcrumbList","@id":"https:\/\/psychedelichealth.co.uk\/2023\/08\/10\/study-psilocybin-gambling-addiction\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/34.142.66.208\/"},{"@type":"ListItem","position":2,"name":"World first study to explore psilocybin for gambling addiction"}]},{"@type":"WebSite","@id":"https:\/\/34.142.66.208\/#website","url":"https:\/\/34.142.66.208\/","name":"Psychedelic Health","description":"News","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/34.142.66.208\/?s={search_term_string}"},"query-input":"required name=search_term_string"}],"inLanguage":"en-GB"},{"@type":"Person","@id":"https:\/\/34.142.66.208\/#\/schema\/person\/188c12739a5906cf0b69fbf53f517f12","name":"Stephanie Price","image":{"@type":"ImageObject","inLanguage":"en-GB","@id":"https:\/\/34.142.66.208\/#\/schema\/person\/image\/","url":"https:\/\/psychedelichealth.co.uk\/wp-content\/uploads\/2023\/05\/avatar_user_20_1684313043-96x96.jpg","contentUrl":"https:\/\/psychedelichealth.co.uk\/wp-content\/uploads\/2023\/05\/avatar_user_20_1684313043-96x96.jpg","caption":"Stephanie Price"},"description":"Stephanie is the editor of Psychedelic Health. Contact: stephanie@psych.global. Stephanie is a journalist writing about science, research, policy and industry developments in cannabis, CBD and psychedelics. In 2013 Stephanie gained her BA in English and Media, focusing on journalism and propaganda, and in 2015, received her National Council for the Training of Journalists (NCTJ) diploma whilst working as a reporter in North Wales. Stephanie has a specialism in Medical Cannabis: The Health Effects of THC and CBD through the University of Colorado, Boulder, and a certificate from the Medical Cannabis Clinicians Society on \"Medical Cannabis Explained\".","sameAs":["https:\/\/psychedelichealth.co.uk","https:\/\/twitter.com\/https:\/\/twitter.com\/steph_jprice"],"url":"https:\/\/psychedelichealth.co.uk\/author\/stephanieprice\/"}]}},"amp_enabled":true,"_links":{"self":[{"href":"https:\/\/psychedelichealth.co.uk\/wp-json\/wp\/v2\/posts\/18519"}],"collection":[{"href":"https:\/\/psychedelichealth.co.uk\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/psychedelichealth.co.uk\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/psychedelichealth.co.uk\/wp-json\/wp\/v2\/users\/20"}],"replies":[{"embeddable":true,"href":"https:\/\/psychedelichealth.co.uk\/wp-json\/wp\/v2\/comments?post=18519"}],"version-history":[{"count":10,"href":"https:\/\/psychedelichealth.co.uk\/wp-json\/wp\/v2\/posts\/18519\/revisions"}],"predecessor-version":[{"id":18529,"href":"https:\/\/psychedelichealth.co.uk\/wp-json\/wp\/v2\/posts\/18519\/revisions\/18529"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/psychedelichealth.co.uk\/wp-json\/wp\/v2\/media\/17282"}],"wp:attachment":[{"href":"https:\/\/psychedelichealth.co.uk\/wp-json\/wp\/v2\/media?parent=18519"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/psychedelichealth.co.uk\/wp-json\/wp\/v2\/categories?post=18519"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/psychedelichealth.co.uk\/wp-json\/wp\/v2\/tags?post=18519"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}